特朗普政府据悉考虑将美国药品价格降至国际水平。

Core Viewpoint - The Trump administration is reportedly considering reducing U.S. drug prices to align with international levels [1] Group 1 - The potential policy change aims to address the high cost of prescription drugs in the United States [1] - This initiative may impact pharmaceutical companies' pricing strategies and profit margins [1] - Aligning drug prices with international standards could lead to significant savings for consumers [1]